Searchable abstracts of presentations at key conferences in endocrinology

ea0077lb24 | Late Breaking | SFEBES2021

Hypopituitarism caused by Langerhans Cell Histiocytosis

Curtis Louise , Page Georgina , Richardson Tristan , Holt Helen

Langerhans Cell Histiocytosis is an inflammatory myeloid neoplasia caused by mutations of several genes in the MAPKinase (MAPK) pathway which can present in single or multiple sites. Our patient presented to her GP with several months of amenorrhoea, thirst, tiredness and 3 stone weight loss. She was previously fit and well, working, and married with children. Blood tests revealed panhypopituitarism with low 9am cortisol 117 nmol/l (133-537). Oestrogen and gonadotrophins were ...

ea0077lb28 | Late Breaking | SFEBES2021

A Heavy Heart

Curtis Louise , Richardson Tristan , Page Georgina , Holt Helen

Anabolic androgenic steroids (AAS) are class C drugs with adverse effects on health. Prevalence is increasing, often with a lack of awareness of the dangers. We present the case of a 33 year-old male with dilated cardiomyopathy and polycythaemia apparently due to AAS abuse over three years. The patient presented with five weeks of increasing breathlessness and chest tightness. Examination revealed evidence of congestive cardiac failure. Chest radiograph showed evidence of pulm...

ea0038p487 | Thyroid | SFEBES2015

A case of thyroid hormone resistance with unusually elevated free thyroxine

Curtis Louise , Page Georgina , Partridge Helen , Holt Helen , Richardson Tristan

A 21 year old Caucasian female with no known personal or family history of thyroid disease presented with several years history of anxiety and was found to have abnormal thyroid function tests. Results showed TSH: 1.8 mu/l (0.3–5.5), T4: 73 pmol/l (10–22), T3 12.3 pmol/l (3.1–6.8). Past medical history included chronic anxiety with no regular medications or nutritional supplements. There was no history of recent iodinated contrast administr...

ea0059p076 | Clinical practice, governance & case reports | SFEBES2018

Outcomes of endoscopic surgical intervention for acromegaly – the Wessex experience

Curtis Louise , Mathad N , Chakraborty Aabir , Brewster Sarah , Millar Kate , Parsad Meenakshi , Al-Mrayat Ma'en

Background: Transsphenoidal surgery is the primary therapy in majority of Acromegaly patients with GH-secreting somatotroph adenomas. Reported outcomes of surgery show an initial remission rate of 40–50% for macroadenomas and >85% for microadenomas. Rates of hypopituitarism following endoscopic pituitary decompression vary between 5 and 25%. Invasion of cavernous sinus indicates the tumour is unlikely to be resectable.Methods: We audited the res...